{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:50:30Z","timestamp":1786737030822,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ijp.ijp_788_19","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T09:06:29Z","timestamp":1596531989000},"page":"222","source":"Crossref","is-referenced-by-count":4,"title":["Target\/therapies for chronic recurrent erythema nodosum leprosum"],"prefix":"10.4103","volume":"52","author":[{"given":"Pugazhenthan","family":"Thangaraju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShobanBabu","family":"Varthya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajitha","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.291395-1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1489\/1544-581X(2004)072<0125:ECOLRY>2.0.CO;2","article-title":"Epidemiological characteristics of leprosy reactions: 15 years experience from north India","author":"Kumar","year":"2004","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"key-10.4103\/0253-7613.291395-2","doi-asserted-by":"crossref","first-page":"868","DOI":"10.4269\/ajtmh.2006.74.868","article-title":"Clinical course of erythema nodosum leprosum: An 11-year cohort study in Hyderabad, India","author":"Pocaterra","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.4103\/0253-7613.291395-3","first-page":"479","article-title":"Metformin, an antidiabetic drug as a therapeutic agent in the treatment of moderate to severe chronic erythema nodosum leprosum","author":"Thangaraju","year":"2016","journal-title":"Fontilles Rev leprol"},{"key":"key-10.4103\/0253-7613.291395-4","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4103\/0378-6323.120719","article-title":"New insights in the pathogenesis of type 1 and type 2 lepra reaction","author":"Pandhi","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0253-7613.291395-5","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3109\/13880209.2015.1057652","article-title":"Metformin inhibits proliferation and proinflammatory cytokines of human keratinocytesin vitro via mTOR-signaling pathway","author":"Liu","year":"2016","journal-title":"Pharm Biol"},{"key":"key-10.4103\/0253-7613.291395-6","doi-asserted-by":"crossref","first-page":"23246","DOI":"10.1074\/jbc.M114.577908","article-title":"Metformin suppresses lipopolysaccharide (LPS)-induced inflammatory response in murine macrophages via activating transcription factor-3 (ATF-3) induction","author":"Kim","year":"2014","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0253-7613.291395-7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1124\/jpet.109.164970","article-title":"Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro","author":"Arai","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"key-10.4103\/0253-7613.291395-8","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.0000221429.94591.72","article-title":"Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells","author":"Hattori","year":"2006","journal-title":"Hypertension"},{"key":"key-10.4103\/0253-7613.291395-9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2014.05.003","article-title":"Chronic treatment with metformin suppresses toll-like receptor 4 signaling and attenuates left ventricular dysfunction following myocardial infarction","author":"Soraya","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"key-10.4103\/0253-7613.291395-10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.intimp.2013.03.020","article-title":"Metformin downregulates Th17 cells differentiation and attenuates murine autoimmune arthritis","author":"Kang","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"key-10.4103\/0253-7613.291395-11","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/j.1476-5381.2010.01126.x","article-title":"Metformin inhibits HMGB1 release in LPS-treated RAW264.7 cells and increases survival rate of endotoxaemic mice","author":"Tsoyi","year":"2011","journal-title":"Br J Pharmacol"},{"key":"key-10.4103\/0253-7613.291395-12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1530\/EJE-07-0815","article-title":"Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes","author":"Lund","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/0253-7613.291395-13","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.metabol.2009.10.007","article-title":"Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients","author":"Derosa","year":"2010","journal-title":"Metabolism"},{"key":"key-10.4103\/0253-7613.291395-14","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1517\/14656566.2012.734499","article-title":"Vildagliptin action on some adipocytokine levels in type 2 diabetic patients: A 12-month, placebo-controlled study","author":"Derosa","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"key-10.4103\/0253-7613.291395-15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.atherosclerosis.2012.09.034","article-title":"Lymphocyte-suppressing and systemic anti-inflammatory effects of high-dose metformin in simvastatin-treated patients with impaired fasting glucose","author":"Krysiak","year":"2012","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/0253-7613.291395-16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.mayocp.2012.02.014","article-title":"Effect of insulin sensitizer therapy on atherothrombotic and inflammatory profiles associated with insulin resistance","author":"McCoy","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"key-10.4103\/0253-7613.291395-17","first-page":"3440","article-title":"Chemerin and apelin are positively correlated with inflammation in obese type 2 diabetic patients","author":"Yu","year":"2012","journal-title":"Chin Med J (Engl)"},{"key":"key-10.4103\/0253-7613.291395-18","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.2169\/internalmedicine.52.8175","article-title":"Variations in inflammatory biomarkers following the addition of sitagliptin in patients with type 2 diabetes not controlled with metformin","author":"Derosa","year":"2013","journal-title":"Intern Med"},{"key":"key-10.4103\/0253-7613.291395-19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.trsl.2015.06.002","article-title":"Metformin ameliorates the proinflammatory state in patients with carotid artery atherosclerosis through sirtuin 1 induction","author":"Xu","year":"2015","journal-title":"Transl Res"},{"key":"key-10.4103\/0253-7613.291395-20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1378\/chest.118.2.503","article-title":"Proinflammatory cytokines","author":"Dinarello","year":"2000","journal-title":"Chest"},{"key":"key-10.4103\/0253-7613.291395-21","doi-asserted-by":"crossref","unstructured":"Kar HK, Sharma P. Leprosy reactions. In: Kar HK, Kumar B, editors. IAL Text Book of Leprosy. 1st ed. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd.; 2010. p. 269-89.","DOI":"10.5005\/jp\/books\/11431_22"},{"key":"key-10.4103\/0253-7613.291395-22","unstructured":"Pfaltzgraff RE, Ramu G. Clinical leprosy. In: Hastings RC, editor. Leprosy. 2nd ed. New York: Churchill Livingstone; 1994. p. 237-87."},{"key":"key-10.4103\/0253-7613.291395-23","unstructured":"Harth W, Gieler W, Kusnir D, Tausk FA, editors. Clinical Management in Psychodermatology. 1st ed. Berlin, Heidelberg: Springer Verlag; 2009."},{"key":"key-10.4103\/0253-7613.291395-24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4103\/0019-5154.127678","article-title":"Hypnotherapy: A useful adjunctive therapeutic modality in Hansen's disease","author":"Latheef","year":"2014","journal-title":"Indian J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5154","issn-type":"print"},{"key":"key-10.4103\/0253-7613.291395-25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbi.2011.12.011","article-title":"A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia","author":"Tynan","year":"2012","journal-title":"Brain Behav Immun"},{"key":"key-10.4103\/0253-7613.291395-26","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.neuropharm.2012.10.002","article-title":"A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: Do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression?","author":"Walker","year":"2013","journal-title":"Neuropharmacology"},{"key":"key-10.4103\/0253-7613.291395-27","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1073\/pnas.0510965103","article-title":"Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses","author":"Chi","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0253-7613.291395-28","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1378\/chest.117.4.1162","article-title":"Anti-inflammatory cytokines","author":"Opal","year":"2000","journal-title":"Chest"},{"key":"key-10.4103\/0253-7613.291395-29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4110\/in.2013.13.4.123","article-title":"Metformin down-regulates TNF-\u03b1 Secretion via suppression of scavenger receptors in macrophages","author":"Hyun","year":"2013","journal-title":"Immune Netw"},{"key":"key-10.4103\/0253-7613.291395-30","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/euhj.2001.2805","article-title":"Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men","author":"Skoog","year":"2002","journal-title":"Eur Heart J"},{"key":"key-10.4103\/0253-7613.291395-31","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/cvr\/cvn120","article-title":"Cytokines and atherosclerosis: A comprehensive review of studies in mice","author":"Kleemann","year":"2008","journal-title":"Cardiovasc Res"},{"key":"key-10.4103\/0253-7613.291395-32","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.cellbi.2007.06.009","article-title":"Interleukin-10 inhibits the down-regulation of ATP binding cassette transporter A1 by tumour necrosis factor-alpha in THP-1 macrophage-derived foam cells","author":"Mei","year":"2007","journal-title":"Cell Biol Int"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:49:11Z","timestamp":1786733351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.IJP_788_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"alternative-id":["291395"],"URL":"https:\/\/doi.org\/10.4103\/ijp.ijp_788_19","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}